Kodiak Sciences Q1 Loss Widens
03:06 PM EDT, 05/10/2021 (MT Newswires) -- Kodiak Sciences (KOD) on Monday said its net loss widened to $0.98 per share from $0.54 per share a year earlier, inline with the consensus estimate from analysts polled by Capital IQ.
The drug maker focusing on retinal diseases had no revenue in the quarter.
Kodiak ended the quarter with $929 million of cash, cash equivalents and marketable securities.
The stock was down more than 11% in afternoon trading.
Price: 89.31, Change: -12.32, Percent Change: -12.12